You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

locally advanced, unresectable breast cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)

Recruiting
  • Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +2 more
Oct 25, 2022

HER2-positive Metastatic Breast Cancer Trial in Aurora, Madison (Alpelisib, Tucatinib, Fulvestrant)

Recruiting
  • HER2-positive Metastatic Breast Cancer
  • Aurora, Colorado
  • +2 more
Dec 29, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Breast Tumors Trial in Spain (No intervention)

Recruiting
  • Breast Neoplasms
  • No intervention
  • Elche, Alicante, Spain
  • +39 more
Jan 20, 2023

Breast Cancer Trial in Shanghai (A166)

Recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 6, 2022

Breast Adenocarcinoma, Metastatic Triple-Negative Breast Carcinoma, Stage III Breast Cancer AJCC v7 Trial in Jacksonville (drug,

Active, not recruiting
  • Breast Adenocarcinoma
  • +6 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Dec 14, 2021

Breast Cancer Trial in Japan, Korea, Republic of, Taiwan (Tucatinib, Trastuzumab, Capecitabine)

Active, not recruiting
  • Breast Cancer
  • Nagoya, Aichi, Japan
  • +27 more
Nov 30, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +3 more
  • (no location specified)
Jun 28, 2022

Advanced Breast Cancer, Metastatic Breast Cancer Trial in China (MRG002)

Recruiting
  • Advanced Breast Cancer
  • Metastatic Breast Cancer
  • Hefei, Anhui, China
  • +18 more
Nov 29, 2021

Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)

Active, not recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Duarte, California
  • +4 more
Jul 16, 2022

Triple Negative Breast Cancer Trial in United States (Trilaciclib, Sacituzumab Govitecan-hziy)

Recruiting
  • Triple Negative Breast Cancer
  • Chandler, Arizona
  • +21 more
Oct 25, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Triple Negative Breast Cancer Trial in Portugal, Spain (Ipatasertib, Capecitabine, Eribulin)

Recruiting
  • Triple Negative Breast Cancer
  • Amadora, Lisboa, Portugal
  • +16 more
Jun 10, 2022

Metastatic Breast Cancer Trial in Villejuif (U3-1402)

Recruiting
  • Metastatic Breast Cancer
  • Villejuif, France
    Gustave Roussy
Jul 7, 2021

Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • FOLFIRINOX treatment
  • (no location specified)
Aug 9, 2023

Triple Negative Breast Tumors Trial in Worldwide (ladiratuzumab vedotin, Pembrolizumab)

Recruiting
  • Triple Negative Breast Neoplasms
  • Birmingham, Alabama
  • +49 more
Jan 4, 2023

Locally Advanced (Inoperable) or Metastatic Breast Cancer Trial in Worldwide (Capivasertib, Matched Capivasertib Placebo,

Recruiting
  • Locally Advanced (Inoperable) or Metastatic Breast Cancer
  • Los Angeles, California
  • +76 more
Nov 25, 2022

HER2-positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer Trial in Ireland, Spain (Copanlisib,

Terminated
  • HER2-positive Breast Cancer
  • +3 more
  • Cork, Ireland
  • +3 more
Dec 14, 2020

Breast Cancer Trial in Tokyo (Paclitaxel + bevacizumab therapy, Paclitaxel + bevacizumab + atezolizumab)

Recruiting
  • Breast Cancer
  • Paclitaxel + bevacizumab therapy
  • Paclitaxel + bevacizumab + atezolizumab
  • Tokyo, Japan
    Cancer Institute Hospital of JFCR
Feb 28, 2021

Triple-Negative Breast Cancer Trial in Shanghai (VEGFR, nab-paclitaxel, Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin)

Recruiting
  • Triple-Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Mar 28, 2023

HER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer Trial in India (Trastuzumab emtansine)

Completed
Has Results
  • HER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer
  • Trastuzumab emtansine
  • New Delhi, Delhi, India
  • +12 more
Mar 31, 2021

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ocala, Florida
    Ocala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023

Pre-analytical Factors Affecting ctDNA Analysis in Early and

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +4 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jul 6, 2023

Triple-Negative Breast Cancer Trial in Shanghai (Famitinib, Camrelizumab, nab-Palitaxel/Capecitabine/Eribulin

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Feb 27, 2023

Sentinel Lymph Node, Breast Cancer, Locally Advanced Trial in Hospitalet de Llobregat, Barcelona (Target Axillary Dissection)

Recruiting
  • Sentinel Lymph Node
  • +2 more
  • Target Axillary Dissection
  • Hospitalet de Llobregat, Barcelona, Spain
  • +1 more
Mar 11, 2023